This is the first entry in a two-part series describing my recent experiences with genetic testing through 23andMe. Although I was most excited by the genetic genealogy information provided by the results, I thought that readers might be interested in some of the health and trait information as well. If I forget to discuss something, feel free to ask in the comments and I’ll do my best to respond.
Note that this discussion is limited to a cursory analysis of my results. Anyone who is considering testing through 23andMe should be aware that scientists are only just beginning to study and understand the connection between genetics and health, and thus the results are not meant to be interpreted as absolutes. Be sure to analyze your own results with this caveat in mind, and do your own research into the testing process.
In October 2007, I wrote about the launch of GeneTree (see â€œSorenson Genomicâ€™s GeneTree Launchesâ€), a â€œDNA-enabled family history-sharing Web site.â€Â Today, GeneTree has announced that it is out of beta and has added advanced features for users.
Following is the press release from GeneTree:
SALT LAKE CITY (March 9, 2009)â€”GeneTree today announced its free family Web site has completed beta testing and now offers those who sign in a simple, intuitive way to regularly communicate with their extended family and to securely share and store family contact information, personal profiles, photos, video and ancestry documents. Advanced features now available through GeneTreeâ€™s redesigned graphic interface include GEDCOM file-format import for family tree collaboration, paternal line genetic genealogy and an all-new family tree building tool.
Image via CrunchBase
DAVIDE at the European Genetics and Anthropology Blog recently posted two interviews (here and here) with customers of 23andMeâ€™s large-scale genome scanning service, one from Finland and one from the U.S.
Itâ€™s very interesting to see the responses of these anonymous individuals, particularly since they are from different countries.
For example, both were asked why they decided to purchase the 23andMe test – â€œWas it to test your ancestry or genetic health risk factors?â€Â Interestingly, for both individuals ancestry was the motivating factor behind testing.Â More support for my conclusion that these companies should strongly promote the ancestral aspects of their products.
Here are a few examples of other questions in the interviews:
In February, I received a number of comments and emails which suggested that DNAPrint Genomics was not processing results and could not be reached by telephone.Â DNAPrint was one of the first companies to offer â€˜large-scaleâ€™ autosomal testing, although their tests were unable to compete with the testing currently offered by companies like 23andMe and deCODEme.
Indeed, the company has recently ceased operations.Â From the site: â€œDNAPrintÂ® Genomics, Inc. has regrettably ceased operations. We thank you for your support.â€Â As I wrote last February, the company was scheduled to be purchased by Nanobac Pharmaceuticals, but the deal fell through shortly thereafter.
GenomeWeb Announces DNAPrint’s Demise
From an announcement today at GenomeWeb – â€œDNAPrint Genomics Goes Bustâ€:
Image via CrunchBase
This isnâ€™t about genetic genealogy or even genealogy, but itâ€™s too interesting to pass up.
A recent Fortune article titled â€œHow Facebook is taking over our livesâ€ points out that roughly 175 million people are members of Facebook, and that the total daily use of Facebook is over 3 billion minutes.
Here are some rough calculations using that 3 billion minutes per day value (and feel free to check my math, please!):Â three billion minutes equals 50 million hours, which equals 2.08 million days, which equals 5,707 years.
Thus, every single day humanity spends the equivalent of over 5,000 years on Facebook!
Image via Wikipedia
In â€œCalled back to Africa by DNA,â€ journalist Teresa Watanabe highlights the recent surge of interest in the genetic genealogy by African Americans.Â This increased interest is often written about during February, which is Black History Month (see â€œGenetic Genealogy and Black History Monthâ€ from February 2008 and â€œDNA Testing Jumps During Black History Monthâ€ from February 2007).Â Although the LA times article rehashes some of the same issues, it also contributes a number of new points to the conversation.
Among other things, the article mentions several of the projects that focus on African American genetic genealogy, including African Ancestry:
The curiosity has fueled the growth of DNA testing outfits. African Ancestry Inc., a Washington-based firm, has tested the DNA of 15,000 people against its database of 25,000 African genetic lineages, according to its president, Gina M. Paige. The firm’s clients include Winfrey, film director Spike Lee, musician Quincy Jones, comedian Whoopi Goldberg and actors Morgan Freeman and Don Cheadle.
Peter Dizikes at Salon.com writes “Your DNA is a Snitch,” about privacy concerns surrounding genetic testing. Peter contacted me a little while ago and we talked about some of my thoughts on the topic. My opinion on the security measures at genetic testing companies was included in the story:
Early-adopting customers tend to agree [that genetic testing companies can protect personal information]. “They have every incentive to keep information private,” says Blaine Bettinger, a law student and genetics blogger in New York state and a 23andMe customer.” A security breach would be devastating for those companies.” Certainly well-funded firms like Navigenics and 23andMe can devote substantial resources to data protection.
Iâ€™ve been working on a presentation regarding the future of genetic genealogy, and one aspect of that future is the ability to trace DNA (SNPs, mutations, haplogroups, etcâ€¦) through recent history as the result of combining extensive genomic sequencing with massive family tree information.Â Although the ability to do this will have many uses (both for genealogy and for personalized medicine), it will also raise a number of privacy issues, as a recent paper suggests.
A New Privacy Study
In â€œInferential Genotyping of Y Chromosomes in Latter-Day Saints Founders and Comparison to Utah Samples in the HapMap Project,â€ author Jane Gitschier uses a combination of FamilySearch (http://www.familysearch.org) and Sorenson Molecular Genealogy Foundation (http://www.smgf.org/) to elucidate the Y-chromosome signature of two founders of the LDS Church.Â Gitschier then used that information to determine whether anyone who contributed DNA to the HapMap project was related to these individuals via the Y-chromosome (none appeared to be).Â However, Gitschier was able to predict the surname of many of the HapMap participants using these databases.
In November 2007 I estimated that as of that date 600,000 to 700,000 DNA testing kits had been sold by genetic genealogy companies and that the number was increasing by 80,000 to 100,000 kits per yearÂ (see â€œHow Big is the Genetic Genealogy Market?â€).Â I ended that article with a prediction:Â â€œAs the interest in genetic genealogy grows, I predict that the 1 millionth genetic genealogy customer will push the â€˜buyâ€™ button as early as 2009.â€
It seems my prediction might not have been too far off.Â This week, Family Tree DNA issued a press release stating that the company had recently received an order for the 500,000th testing kit.
FTDNA’s Press Release:
HOUSTON, February 9, 2009 (For Immediate Release) – Family Tree DNA (http://www.familytreedna.com), the world leader in genetic genealogy, announced today that it received its 500,000th DNA test order for genealogy and anthropology purposes.
23andMe and mondoBIOTECH announced at Davos (the World Economic Forum in Switzerland) today that they will work together to further the study of rare diseases.Â According to the press release (below), mondoBIOTECH will identify individuals suffering from certain rare diseases and sponsor their enrollment in the 23andMe Personal Genome Serviceâ„¢.Â Researchers will use the information collected to learn more about the potential causes of these rare diseases.
Linda Avey appeared on CNBC this morning to discuss the company and the partnership â€“ see â€œIt’s All in the Genes.â€
The Press Release:
Davos, Switzerland â€“ January 28th 2009 â€“ 23andMe, Inc., an industry leader in personal genetics, and Mondobiotech AG, a Swiss research company dedicated to the development of treatments for rare diseases, today announced at the World Economic Forum in Davos, Switzerland, that they are collaborating to advance research of rare diseases.